MedTrace Logo

Identifying Biomarkers of Gastro Intestinal Comorbidities in Autism Spectrum Disorder

NCT07744217 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 23

Last updated 2026-08-04

No results posted yet for this study

Summary

This study investigates the microbiome-gut-brain axis in pediatric autism spectrum disorder (ASD). By longitudinally tracking participants, the study evaluates whether multi-omic profiles (gut microbiota and metabolome) correlate with behavioral and gastrointestinal fluctuations over time.

Conditions

  • Autism
  • Gastro Intestinal Diseases

Sponsors & Collaborators

Eligibility

Min Age
5 Years
Max Age
19 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-02-03
Primary Completion
2025-02-09
Completion
2026-03-06

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07744217 on ClinicalTrials.gov